Biotech Affimed Announces Approval of Clinical Trial Application in France for a Phase 1 Study of AFM28 in Relapsed/Refractory Acute Myeloid Leukemia December 22, 2022
Biotech CLASS ACTION UPDATE for EIGR, VERU and NBEVQ: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders December 21, 2022
Biotech Achieve Life Sciences Announces Patent Granted by USPTO for New Cytisinicline Formulation December 21, 2022
Biotech EIGER BIOPHARMACEUTICALS, INC. (NASDAQ:EIGR) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) December 21, 2022
Biotech Celyad Oncology provides an update on its strategic business model, continuing to focus on opportunities to fully harness the true potential of its proprietary technology platforms and intellectual property December 21, 2022
Biotech CLASS ACTION UPDATE for FRSH, SEDG and EIGR: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders December 20, 2022
Biotech Journey Medical Corporation Announces Positive Comparative Pharmacokinetic (PK) Data for DFD-29 December 20, 2022
Biotech Eyenovia Announces Participation at the 2023 International Consumer Electronics Show December 20, 2022
Biotech BioLineRx Announces Results from Phase 1/2a Study of Investigational Anti-Tumor Vaccine AGI-134 in Metastatic Solid Tumors December 20, 2022
Biotech ContraFect Provides Update from the Futility Analysis of the Phase 3 DISRUPT Study of Exebacase December 19, 2022